Nurturing Agricultural Biotechnology 2025

-
The report covers the analysis and forecast of the agricultural biotechnology market on global as well as regional level. The study provides historical data from 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).

The study provides a detailed view of the Agricultural biotechnology market, by segmenting it based on by product type, by Technology, by end- user and regional demand. Fast changes in technical fields such as DNA sequencing and genome excision in the past several years propels the growth for the agricultural biotechnology market. Growing demand for biofuel is another prime factor driving the market 




Demand. Additionally, rising population globally is one the key factor that fuels the demand of this market. Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The segmentation also includes by product type, and by technology in all regions. These include different business strategies adopted by the leading players and their recent developments.

The report provides the size of the agricultural biotechnology market in 2017 and the forecast for the next eight years up to 2025. The size of the global agricultural biotechnology market is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Asia Pacific, Middle East and Africa and Latin America has been taken into account in estimating the growth of the global market.

Market estimates for this study have been based on revenue being derived through regional pricing trends. The agricultural biotechnology market has been analyzed based on expected demand. The bottom-up approach is done to estimate the global revenue of the agricultural biotechnology market, split into regions. Based on product type, and technology the individual revenues from all the regions is summed up to achieve the global revenue for agricultural biotechnology. Companies were considered for the market share analysis, based on their innovation and revenue generation. In the absence of specific data related to the sales of agricultural biotechnology several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence.

The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include Adama Agricultural Solution Ltd., Bayer CropScience AG, Certis USA, Dow Agroscience LLC, Du Pont Pioneer Hi-Bred, Evogene Ltd., Global Bio-Chem Technology, KWS SAAT AG, Monsanto, and Syngenta AG

The global agricultural biotechnology market has been segmented into:

Global Agricultural Biotechnology Market: By Product Type
• Transgenic seeds
o Maize
o Fruits & vegetables
o Soyabean
o Others
• Crop protection products
o Biopesticides
o Biotimultants

Global Agricultural Biotechnology Market: By Technology
• Genome editing tools
• Synthetic biology
• Deoxy ribonucleic acid sequencing (DNA)
• Ribonucleic acid interference
• Biochip

Related Reports 

Comments

Post a Comment

Popular posts from this blog

India travels across!

-
Image
Tourism is a cultural and provisional base for any nation. India is democratic and has shown enormous growth trends in outbound tourism. Prevailing estimation proposes that India has moved up becoming the 8th largest outbound travel market destination of the world. India outbound tourism market has risen considerably in recent years, giving tremendous profits to tours and travel companies abroad. CULMINATION According to the research of India Travel and Tourism market , most of the major players of tourism business over the globe are looking to invest in the expenses of India's population. Thus, capitalizing the overall annual growth with outbound meetings, incentives, conferences, and exhibitions. The recent estimated value of India's travel business has reached a whopping 95-billion-dollar extension with the major push being the US. This data was released and evaluated greatly in compliance with the travel and tourism market reports from...
Read more

A detailed SWOT report on A.P. Moller – Maersk

-
Image
A.P. Moller - Maersk AS (MAERSK B) - Financial and Strategic SWOT Analysis The review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers, and competitors better. The profile contains critical company information including: ·         Business description – A detailed description of the company’s operations and business divisions. ·         Corporate strategy – Analyst’s summarization of the company’s business strategy. ·         SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities, and threats. · ...
Read more

Human Parainfluenza Virus 3 Infections, H1 2018

-
Image
Human parainfluenza virus 3 is a life-threatening infection that causes respiratory illnesses in infants and young children. Symptoms include fever, cough, runny nose, croup, bronchiolitis, wheezing and sore throat. Treatment includes over-the-counter medications for pain and fever. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Human Parainfluenza Virus 3 Infections (Infectious Disease). The pipeline guide reviews pipeline therapeutics for Human Parainfluenza Virus 3 Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources. The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. The pipeline guide features descriptive drug profiles for the pipeline products which compris...
Read more